Database

Startups

Main Industry
Biotechnology
Main Product/Service
HUKUI Bio offers a range of medical devices, including point-of-care diagnostics such as glucose test strips and uric acid test strips.
The company is also developing wearable health-monitoring devices (e.g., a smart ring), miniature endoscopic lenses, a
The content above was translated by Ai
Founded Year
2013
Unified Business No.
54648808
Status
Active
Number of Employees
0
Total Paid-in Capital
793,584,440 (NT$)
Location of Company
Taiwan , Taipei City
Company names, registration status, legal representatives, founding years, paid-in capital, registered addresses, and other details are sourced from business registration records maintained by Taiwan’s Administration of Commerce, Ministry of Economic Affairs. Exit status includes Emerging Stock Board listings, M&A, and IPOs. Information on overseas expansion is self-reported by startups. Note 1: FINDIT compiles company information from public and other sources for reference and does not serve as a point of contact for the companies listed. Note 2: Some company profiles and product/service descriptions are translated using AI and provided for reference only. In case of discrepancies or ambiguity, the original text prevails.
About the Company

Established in 2013, HUKUI is a distinguished Contract Development and Manufacturing Organization (CDMO) specializing in electronic and medical devices. Leveraging Taiwan’s deep electronic and semiconductor industry expertise and integrated supply chain connections, HUKUI delivers superior Design Engineering Solutions, global regulatory affairs registration services, and a broad spectrum of electronics manufacturing from simple to complex.

The content above was translated by Ai
more ↓

Similar Companies

null

[Customized Services] null provides customized drug research and development (R&D) and manufacturing services, covering process development, analytical method development, and cGMP manufacturing services for preclinical, clinical, and post-marketing stages of new drugs, as well as generic active pharmaceutical ingredients (APIs) and intermediates. The scope of services includes process development, process scale-up and validation, analytical method development and validation, intermediate and API manufacturing, stability testing, and assistance with relevant regulatory filings.

[Research and Process Development] null possesses strong advantages in chemical synthesis technology and expertise. Within the company, the Process Technology Service Department and the Analytical Technology Service Department work seamlessly together to produce Process Development Reports (PDRs). These reports detail the work and conclusions regarding synthetic routes, processes, experimental results, relevant analytical data, and cGMP-related activities during the development period. PDRs provide a scientific basis for continuous improvement and change control in regulatory registration and filings for preclinical stages, clinical trial entry, and commercial mass production.

[Analytical Services] In addition, null also provides analytical services, such as analytical method research, development, and quality control; reference standard identification and characterization; cGMP process control; testing and release of intermediates and finished products; and regulatory-compliant stability testing services.

[Manufacturing] Lastly, null also provides manufacturing services, including real-time cGMP development, manufacturing, and the production of high-quality products.
回頁面最頂端